Apuli Maricel
SEC insider (Form 3/4/5 filer). CIK 0002058197. Chief Accounting Officer at BridgeBio Pharma, Inc. (BBIO). 16 reported Form 4/5 transactions since Sep 2024; latest on Aug 16, 2026. Located in PALO ALTO, CA.
Companies Apuli Maricel has filed insider reports for
- BridgeBio Pharma, Inc. (BBIO): Officer, Chief Accounting Officer
Apuli Maricel
CIK: 0002058197
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BridgeBio Pharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Aug 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect4.7K shares at avg. $79.86$376K - Jul 30, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect2K shares at avg. $80.06$160K - May 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect4.7K shares at avg. $66.13$312K - Apr 30, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect2K shares at avg. $71.58$143K - Mar 18, 2026BBIO
BridgeBio Pharma, Inc.
AwardDirect14.2K shares- - Feb 26, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect2K shares at avg. $66.00$132K - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect510 shares at avg. $74.31$38K - Feb 16, 2026BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect4.3K shares at avg. $75.25$327K - Dec 12, 2025BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect2K shares at avg. $75.15$151K - Dec 8, 2025BBIO
BridgeBio Pharma, Inc.
SaleDirect2K shares at avg. $74.26$149K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 4,714 | $79.86 | $376,460 | Direct |
| Jul 30, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 2,000 | $80.06 | $160,120 | Direct |
| May 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 4,714 | $66.13 | $311,737 | Direct |
| Apr 30, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 2,000 | $71.58 | $143,160 | Direct |
| Mar 18, 2026 | BBIO BridgeBio Pharma, Inc. | Award | 14,170 | - | $0 | Direct |
| Feb 26, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 2,000 | $66.00 | $132,000 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 510 | $74.31 | $37,898 | Direct |
| Feb 16, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 4,349 | $75.25 | $327,262 | Direct |
| Dec 12, 2025 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 2,003 | $75.15 | $150,525 | Direct |
| Dec 8, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 2,000 | $74.26 | $148,520 | Direct |
1-10 of 16 transactions